UPDATE – Advaxis Announces Achievement of Second Milestone Under ADXS-HER2 Licensing Agreement with OS Therapies
Non-dilutive capital will support advancement of ADXS-HOT neoantigen program PRINCETON, N.J., April 26, 2021 (GLOBE…
Month: April 2021
22nd Century Delivers 3.6 Million Variable Nicotine Content Research Cigarettes for Independent Scientific Studies
To Date, 22nd Century Has Provided More Than 31 Million Variable Nicotine Content Research Cigarettes for…
G1 Therapeutics Announces Publication of Pooled Results from Pivotal Clinical Program of COSELA™ (trilaciclib) in Clinical Lung Cancer
– Pivotal Program Evaluated the Effects of Administering COSELA Prior to Chemotherapy on Clinically Relevant…
Multi-center Study Demonstrates Significant Reductions in Postoperative Pain and Opioid Use Following Peripheral Nerve Stimulation Treatment
Findings Published as Congress Demands Review of Medicare Coverage for Non-opioid Treatments CLEVELAND, April 26,…
Biosplice Publishes Successful Clinical Trial in Knee Osteoarthritis
Biosplice’s Phase 2b trial for lorecivivint hits primary endpoint in osteoarthritis pain SAN DIEGO, April…
Vallon Pharmaceuticals to Participate at the 4th Annual Neuroscience Innovation Forum
David Baker, President and CEO of Vallon to participate in the virtual Advances in Neuropsychiatry…
INmune Bio, Inc. Announces Participation in Fireside Chat at the B Riley Neurosciences Conference
LA JOLLA, Calif, April 26, 2021 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (the…
Turning Point Therapeutics to Host First Quarter 2021 Conference Call
SAN DIEGO, April 26, 2021 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a…
One World Pharma Announces First Sale of Cuttings in Colombia
LAS VEGAS, NV, April 26, 2021 (GLOBE NEWSWIRE) — via NewMediaWire ‒ One World Pharma…
Better Choice Announces Appointment of Former Blue Buffalo Founding Shareholder, Gil Fronzaglia, to the Board of Directors
NEW YORK, April 26, 2021 (GLOBE NEWSWIRE) — Better Choice Company (OTCQX: BTTR) (“Better Choice”),…
Cassava Sciences Invited by the NIH to Participate in Sachs 4th Annual Neuroscience Innovation Forum
AUSTIN, Texas, April 26, 2021 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage…
Vertex and CRISPR Therapeutics Announce Priority Medicines (PRIME) Designation Granted by the European Medicines Agency to CTX001™ for Transfusion-Dependent Beta Thalassemia
BOSTON and CAMBRIDGE, Mass. and ZUG, Switzerland, April 26, 2021 (GLOBE NEWSWIRE) — Vertex Pharmaceuticals…
Antares Pharma Appoints Dr. Peter Richardson as Executive Vice President, Research and Development and Chief Medical Officer
EWING, N.J., April 26, 2021 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”),…
Advaxis Announces Receipt of Second Milestone Payment Under ADXS-HER2 Licensing Agreement with OS Therapies
Non-dilutive capital to support advancement of ADXS-HOT neoantigen program PRINCETON, N.J., April 26, 2021 (GLOBE…
Saniona to Present at Multiple Upcoming Investor Conferences
PRESS RELEASE April 26, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on…
BioCardia Signs Agreement with Leading Japanese Biotechnology Company for Catheter Biotherapeutic Delivery Product Candidates
Second Biotherapeutic Partnership of 2021 SAN CARLOS, Calif., April 26, 2021 (GLOBE NEWSWIRE) — BioCardia®,…
Vaxart to Host a Key Opinion Leader Webinar on the Importance of T-Cell Responses for COVID-19 Vaccines
Vaxart to provide new data from its Phase I COVID-19 trial Stanford University T-cell expert…
Akero Therapeutics Appoints Yuan Xu to its Board of Directors
SOUTH SAN FRANCISCO, Calif., April 26, 2021 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic…
ADMA Biologics Opens Newest ADMA BioCenters Plasma Collection Facility in Goose Creek, S.C.
RAMSEY, N.J. and BOCA RATON, Fla. and GOOSE CREEK, S.C., April 26, 2021 (GLOBE NEWSWIRE)…
Intercept to Announce First Quarter 2021 Financial Results on May 6, 2021
NEW YORK, April 26, 2021 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company…